The company specializes in drug development designed to leverage therapeutic aspects of psychedelics and serotonergic compounds. Its recent catalysts include a management shakeup and the departure of Dr. Alan Kozikowski as Chief Scientific Offer earlier this summer.
But it may be safe to say that the big move for DRUG stock has more to do with industry sentiment than anything else. In addition, the psychedelic stock is also a low float name as most outlets put this figure below 10 million shares. In this case, it isn't a bad idea to know how to handle volatile trading trends. With low float penny stocks, the moves lower can happen just as quickly as the spikes higher.
Recent DRUG News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/03/2024 03:36:59 PM
- Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events • GlobeNewswire Inc. • 10/03/2024 01:00:00 PM
- Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th • GlobeNewswire Inc. • 09/19/2024 02:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/12/2024 04:58:09 PM
- Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy • PR Newswire (US) • 09/12/2024 12:00:00 PM
- Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy • PR Newswire (Canada) • 09/12/2024 12:00:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/27/2024 01:18:57 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/27/2024 01:10:03 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/13/2024 02:56:48 AM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 01/18/2024 05:57:02 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/29/2023 09:30:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/08/2023 11:00:44 AM
- Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management • PR Newswire (Canada) • 12/06/2023 10:08:00 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM